Zohar 2011b.
Trial name or title | Randomized placebo‐controlled trial of hydrocortisone in PTSD prophylaxis |
Methods | Study type: interventional Allocation: randomised Endpoint classification: efficacy study Intervention model: parallel assignment Masking: double‐blind (subject, caregiver, investigator, outcomes assessor) Primary purpose: prevention |
Participants | Ages eligible for study: no information provided Genders eligible for study: no information provided Inclusion criteria: no information provided |
Interventions | Pharmacological intervention: single injection of 90 to 140 mg (proportioned to body weight) of hydrocortisone |
Outcomes | Primary outcome measures: no information provided Secondary outcome measures: no information provided |
Starting date | August 2011 |
Contact information | Contact: Joseph Zohar, MD; jzohar@post.tau.ac.il Program Officer: Farris K. Tuma; ftuma@mail.nih.gov |
Notes | — |
CAPS: Clinician‐Administered PTSD Scale DSM‐IV: Diagnostic and Statistical Manual IV PTSD: post‐traumatic stress disorder